Friday, 21 November 2008 | 23:00

Home Urology & Nephrology

Overall Decrease In Kidney Cancer Deaths In Europe User Rating: / 0 Saturday, 12 April 2008 Overall deaths from kidney cancer have now fallen across Europe after peaking in the early 1990s, according to a detailed study of mortality rates for 32 countries published in the urology journal BJU International. Read more...   Acute Kidney Injury With Sepsis -- A Unique Pathophysiology User Rating: / 0 Saturday, 12 April 2008 ICU patients with septic acute kidney injury (AKI) are typically sicker, have a higher burden of sickness, a greater risk of mortality and longer stays in hospital than patients with non-septic AKI. Read more...   Major Surgery No Longer Needed For The Removal Of Uterine Fibroids User Rating: / 0 Saturday, 12 April 2008 The treatment of uterine fibroids with 3T MR-guided focused ultrasound (MRgFUS) is safe, non-invasive and effective, according to a recent study conducted by researchers at Weill Cornell Medical College in New York, NY. Read more...   InventHelp Client Invents Catheter Accessory For Patients Using Foley Catheter Urinary Drainage Bags User Rating: / 0 Friday, 11 April 2008 InventHelp announces that 2 of its clients, inventors from Drexel, N.C., have designed a health care accessory for individuals using Foley catheter urinary drainage bags. The inventors have built a prototype. Read more...   Drug Found Safe And Effective In Patients With Chronic Kidney Disease User Rating: / 0 Thursday, 10 April 2008 The osteoporosis drug raloxifene increases bone mineral density and reduces the risk of vertebral fractures among postmenopausal women with mild to moderate chronic kidney disease (CKD), according to a study appearing in the July 2008 issue of the Journal of the American Society Nephrology. Read more...   University Of Queensland Kidney Researcher Attracts International Medal, Australia User Rating: / 0 Thursday, 10 April 2008 University of Queensland researcher Professor Wendy Hoy has been recognised internationally for her work on kidney disease. Professor Hoy has been awarded the United States National Kidney Foundation (NKF) International Distinguished Medal for 2008 at a ceremony in Dallas, Texas. Read more...   Overall Death Due To Kidney Cancer Fall In Europe - But Wide Variations Between Countries Still Exis User Rating: / 0 Wednesday, 09 April 2008 After peaking in the early 1990s, overall kidney cancer deaths have now dropped across Europe, according to a detailed study of mortality rates for 32 countries. The study is published in the journal BJU International (British Journal of Urology International). Read more...   Drexel University College Of Medicine Announces 100th Single Port Access (SPA) Surgery User Rating: / 0 Wednesday, 09 April 2008 Drexel University College of Medicine has announced that physicians here have now completed 100 cases of Single Port Access (SPA™) surgery, a minimally invasive procedure that leaves patients with a hidden scar. Read more...   Urigen Announces Early Closure Of URG101 Phase II Clinical Trial Based On Positive Interim Analysis User Rating: / 0 Wednesday, 09 April 2008 Urigen Pharmaceuticals, Inc. (OTCBB:URGP), http://www.urigen.com, announced the early closure of the URG101-104 study thanks to positive, statistically meaningful interim study results in both the primary and all secondary endpoints. Read more...   Microwave Treatments For Enlarged Prostate Cause Blood Pressure Surges User Rating: / 0 Wednesday, 09 April 2008 Many men who receive microwave therapy for enlarged prostates experience valuable surges in blood pressure that could raise their risk of a heart attack or stroke, according to new research findings published lately in Mayo Clinic Proceedings. Read more...   National Kidney Foundation Introduces Plan To Track Patients In National Screening Program User Rating: / 0 Monday, 07 April 2008 The National Kidney Foundation and Amgen (NASDAQ:AMGN) announced a new initiative of the Kidney Early Evaluation Program (KEEP) that will provide valuable data to help communities address the growing prevalence of chronic kidney disease (CKD). Read more...   OxThera: Pivotal Study Is Being Conducted With Oxabact(TM) For The Treatment Of Primary Hyperoxaluri User Rating: / 0 Monday, 07 April 2008 OxThera announced that all 42 patients have been enrolled in their pivotal phase II/III study using Oxabact™ for the treatment of Primary Hyperoxaluria. Read more...   Affymax And Takeda Report Long-Term Safety And Effectiveness Data Of Hematide In Chronic Renal Failu User Rating: / 0 Monday, 07 April 2008 Affymax, Inc. (Nasdaq:AFFY) and Takeda Global Research & Development announced data from their ongoing Phase 2 trial to assess the long-term safety and tolerability of Hematide™, a potential treatment of anemia. Read more...   Data From Ortho Biotech Sponsored Studies To Be Presented At National Kidney Foundation 2008 Spring User Rating: / 0 Sunday, 06 April 2008 Data from five studies sponsored by Ortho Biotech Products, L.P. will be presented at the National Kidney Foundation (NKF) 2008 Spring Clinical Meetings from April 2 - 6, 2008; 3 utilization studies involve PROCRIT® (Epoetin alfa). Read more...   Scarless Nephrectomy By Transgastric And Transvesical Combined Approach User Rating: / 0 Sunday, 06 April 2008 UroToday.com - Dr. Lima from Porto, Portugal presented the novel concept of "natural orifices translumenal endoscopic surgery" (NOTES) as practical to nephrectomy in an experimental model. Read more...   Management Of Superficial Bladder Tumors: Celecoxib For The Treatment Of Non-Muscle Invasive Bladder User Rating: / 0 Sunday, 06 April 2008 UroToday.com - Cyclooxygenase-2 (Cox-2) expression increases with bladder cancer tumor grade and stage. Read more...   Radical Nephrectomy Is Not Superior To Nephron-Sparing Surgery In PT1b-pT2N0M0 Renal Tumors User Rating: / 0 Sunday, 06 April 2008 Read more...   Management Of Superficial Bladder Tumors: Does Photo Dynamic TURB Improve Outcome Of Initial T1 High User Rating: / 0 Sunday, 06 April 2008 UroToday.com - Long-term Follow-up of a Randomized Study Studies have shown that 5-aminolevulinic acid (5-ALA) induced fluorescence cystoscopy improves the detection of superficial bladder cancer. Read more...   Management Of Superficial Bladder Tumors User Rating: / 0 Sunday, 06 April 2008 UroToday.com - This presentation addressed the issue that recurrence at first follow-up cystoscopy (RR-FFC) after TURBT has been attributed to incomplete resection of the tumor. Read more...   Laparoscopic Renal Cryoablation (LRC) Of Small Renal Masses User Rating: / 0 Sunday, 06 April 2008 UroToday.com - A group from Milan, Italy prospectively analyzed the outcome of patients with kidney masses treated with laparoscopic cryoablation over a 7-year period. Beginning in September 2000, 104 patients (mean age 61.6 years; 78 male and 26 female) underwent LRC for renal masses. Read more...   Safety And Short-Term Efficacy Of Laparoscopic Cryoablation For Renal Tumors ≥ 3 Cm: A Multicenter User Rating: / 0 Sunday, 06 April 2008 UroToday.com - A multicenter European group reported on the short-term outcomes of laparoscopic cryoablation for renal lesions greater than 3cm in size. Read more...   Abbott Launches ZEMPLAR Capsules (paricalcitol) In The UK For Treatment And Prevention Of Common Chr User Rating: / 0 Friday, 04 April 2008 Abbott UK announced the launch of an oral formulation of Zemplar (paricalcitol) for the treatment and prevention of secondary hyperparathyroidism (SHPT), a regular difficulty of chronic kidney disease. Approximately 3 million people in the UK suffer from late stage chronic kidney disease. Read more...   Shire Strives To Increase Adherence Among Chronic Kidney Disease Stage 5 Patients User Rating: / 0 Friday, 04 April 2008 Shire Pharmaceuticals, the global biopharmaceutical company, announced the launch of On Track, an innovative program designed to advance adherence to disease management regimens among chronic kidney disease (CKD) Stage 5 patients with hyperphosphatemia (elevated levels of phosphorus in the blood). Read more...   Nymox Releases Positive New Clinical Trial Data On Response Rates To Company's Prostate Drug NX-1207 User Rating: / 0 Thursday, 03 April 2008 Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced the release of positive new clinical trial data from the Company's newest multi-center U.S. Phase 2 study of NX-1207, Nymox's innovative drug treatment for benign prostatic hyperplasia (BPH). Read more...   Health Benefits Of Drinking Lots Of Water Disputed User Rating: / 0 Thursday, 03 April 2008 A recent look at what is known about the health effects of drinking water reveals that most supposed benefits are not backed by solid evidence. The findings indicate that most people do not need to worry about drinking their recommended 8 glasses of 8 ounces ("8x8") of water per day. Read more...   Men's Health Policy Center Hosts Petition To Protest Government Barrier To Prostate Cancer Medicatio User Rating: / 0 Thursday, 03 April 2008 The Men's Health Policy Center, a new resource center affiliated with the Men's Health Network (MHN), announced that they are hosting an online petition urging Congress to end a Centers for Medicare and Medicaid Services (CMS) practice that unfairly restricts prostate cancer patients' access to... Read more...   Creatinine Increase In Elderly Means Increased Renal Disease, Mortality User Rating: / 0 Thursday, 03 April 2008 Even little increases in serum creatinine levels during hospitalization raise the risk of end stage renal disease and mortality of old patients over the long term, according to a University of Alabama at Birmingham (UAB) study in the March issue of the Archives of Internal Medicine. Read more...   Repros Reports Interim Safety Results From Ongoing One-Year Open Label Study Of Proellex(R) In The T User Rating: / 0 Wednesday, 02 April 2008 Repros Therapeutics Inc. (NasdaqGM:RPRX) announced that the safety of Repros' drug Proellex® appears to be improved with repeated cycles of treatment followed by off drug intervals. Read more...   Research Evaluates The Effectiveness Of Uterine Artery Embolisation (UAE) User Rating: / 0 Tuesday, 01 April 2008 New research published by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme suggests that Uterine Artery Embolisation (UAE) may provide a useful alternative to hysterectomy for the removal of fibroids. Read more...   Lannett Company Receives FDA Approval For Bethanechol Chloride Tablets USP, 5 Mg, 10 Mg, 25 Mg, And User Rating: / 0 Monday, 31 March 2008 Lannett Company, Inc. Read more...

<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>

Results 1 - 30 of 251